Keyword search

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

1 facets displayed. 0 facets selected.

Year of publication

1 facets displayed. 1 facets selected.

Survey or statistical program

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (2)

All (2) ((2 results))

  • Articles and reports: 13-604-M2005049
    Description:

    This note examines the substantial shifts in sector saving and the resulting swings in sector surplus/deficit positions in the national accounts over the last 10 years. It also serves to introduce a new conceptual measure in the Canadian System of National Accounts -- National saving and the national saving rate.

    Release date: 2005-11-30

  • Articles and reports: 88F0006X2005010
    Description:

    This paper looks into Canadian innovative biotechnology firms' access to financing capital. Results show that over 70% of biotech firms that attempted to raise financing capital were successful. Funds were primarily sought for R&D activities and came primarily from Canadian venture capitalists. Harsher market conditions were the main reasons put forward by investors to limit or reject biotechnology firms' funding requests.

    Release date: 2005-04-29
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (2)

Analysis (2) ((2 results))

  • Articles and reports: 13-604-M2005049
    Description:

    This note examines the substantial shifts in sector saving and the resulting swings in sector surplus/deficit positions in the national accounts over the last 10 years. It also serves to introduce a new conceptual measure in the Canadian System of National Accounts -- National saving and the national saving rate.

    Release date: 2005-11-30

  • Articles and reports: 88F0006X2005010
    Description:

    This paper looks into Canadian innovative biotechnology firms' access to financing capital. Results show that over 70% of biotech firms that attempted to raise financing capital were successful. Funds were primarily sought for R&D activities and came primarily from Canadian venture capitalists. Harsher market conditions were the main reasons put forward by investors to limit or reject biotechnology firms' funding requests.

    Release date: 2005-04-29
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: